Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
RECRUITING
NCT04134923

Imaging Biomarkers in Preclinical and Symptomatic AD

Sponsor: Tammie L. S. Benzinger, MD, PhD

View on ClinicalTrials.gov

Summary

The purpose of this research study is to evaluate adult children of parents with and without Alzheimer's disease which represent an ideal population for investigating the biological changes that precede the clinical onset of AD. The investigators will be imaging the brain to detect the presence of amyloid deposits (plaques in the brain). Amyloid is a protein that may be related to dementia of Alzheimer's disease (DAT).

Official title: Imaging Biomarkers in Preclinical and Symptomatic AD. (ACS PiB IND)

Key Details

Gender

All

Age Range

18 Years - Any

Study Type

OBSERVATIONAL

Enrollment

375

Start Date

2021-06-08

Completion Date

2029-10

Last Updated

2025-08-07

Healthy Volunteers

No

Interventions

DRUG

[11C] Pittsburgh Compound-B (PIB)

Participants will receive a single intravenous bolus injection of 6.0 - 20.0 mCi (222-740 MBq) of the investigational radiotracer \[11C\] PIB. Participants will then undergo a \[11C\] PIB PET/CT scan conducted in the Center for Clinical Imaging Research (CCIR) facility.

Locations (1)

Washington University School of Medicine

St Louis, Missouri, United States